The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy ...

A new study showed that psoriasis patients were 1.68 times more likely to acquire onychomycosis than people without psoriasis ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr ...

Valley fever is a fungal lung infection that occurs when you inhale spores from Coccidioides immitis or Coccidioides posadaii. The disease is also called coccidioidomycosis. Symptoms include cough, ...

CTCL accounts for approximately 4% of all non-Hodgkin’s lymphomas and has a median age at diagnosis of 55-65 years. Mycosis fungoides, and Sézary syndrome, its leukemic variant, are the most common ...

Fungal infection, also known as a mycosis, refers to the invasion of a host's tissue by specific types of fungi. Mycoses often start in the lungs following inhalation of fungal spores or on the ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...

It can lead to rash-like redness, scaly patches or plaques, and tumors. The most common type of cutaneous T-cell lymphoma is called mycosis fungoides. A less common form, Sezary syndrome, can lead to ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat adults with relapsed or refractory Sézary syndrome.